Loader

Pathways

PathWhiz ID Pathway Meta Data

PW128407

Pw128407 View Pathway
drug action

Sulfacytine Action Pathway

Escherichia coli (strain K12)
Sulfacytine is a short-acting antibiotic from the sulfonamide drug class. This drug class consists of synthetic bacteriostatic antibiotics with a broad spectrum against most gram-positive and many gram-negative organisms. Sulfacytine is indicated in the treatment of acute urinary tract infections. Sulfacytine inhibits the multiplication of bacteria by acting as a competitive inhibitor of dihydropteroate synthase in the folic acid metabolism cycle. This enzyme does the condensation of the pteridine with the para-aminobenzoic acid (PABA). The inhibition causes the bacteria to stop growing. This drug is administered as an oral tablet but was discontinued in 2006 (FDA).

PW145365

Pw145365 View Pathway
drug action

Sulfacytine Drug Metabolism Action Pathway

Homo sapiens

PW144485

Pw144485 View Pathway
drug action

Sulfadiazine Drug Metabolism Action Pathway

Homo sapiens

PW176136

Pw176136 View Pathway
metabolic

Sulfadiazine Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Sulfadiazine are predicted with biotransformer.

PW145662

Pw145662 View Pathway
drug action

Sulfadimethoxine Drug Metabolism Action Pathway

Homo sapiens

PW176356

Pw176356 View Pathway
metabolic

Sulfadimethoxine Predicted Metabolism Pathway

Homo sapiens
Metabolites of sildenafil are predicted with biotransformer.

PW145366

Pw145366 View Pathway
drug action

Sulfadoxine Drug Metabolism Action Pathway

Homo sapiens

PW176404

Pw176404 View Pathway
metabolic

Sulfadoxine Predicted Metabolism Pathway

Homo sapiens
Metabolites of Sulfadoxine are predicted with biotransformer.

PW128416

Pw128416 View Pathway
drug action

Sulfamerazine Action Pathway

Escherichia coli (strain K12)
Sulfamerazine is an antibacterial agent from the sulfanilamide drug class. It is indicated in the treatment of many infections like bronchitis, prostatitis, and urinary tract infections. Sulfamerazine is a competitive inhibitor of the dihydropteroate synthetase (DHPS). This enzyme is essential in the synthesis of folic acids from para-aminobenzoic acid (PABA) molecules. Sulfamerazine is bacteriostatic, it stops the growth of the bacteria by decreasing the synthesis of bacterial nucleotides and DNA. This drug is administered as an oral tablet.

PW145452

Pw145452 View Pathway
drug action

Sulfamerazine Drug Metabolism Action Pathway

Homo sapiens